Mereo BioPharma MREO
NASDAQ MREO
$0.28 -0.01 (-3.45%)
At close: Oct 23, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Cost of Revenue (2023 - 2025)

Updated

Mereo BioPharma (MREO) recorded Cost of Revenue of $133,000 in FY2025.

Analysis

Mereo BioPharma (MREO) Cost of Revenue (2023 - 2025) Analysis & Trends

Starting with FY2021, Mereo BioPharma's Cost of Revenue history includes 4 years.

  • Annual Cost of Revenue has a four-year compound annual growth rate of -72.8% (FY2021 to FY2025).
  • Per Business Quant data, MREO's Cost of Revenue was $2.57 million in FY2023 (+124.6%), $1.15 million in FY2022 (-95.3%) and $24.14 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Mereo BioPharma 44.71 Mn -105.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 132,000.00
Dec 31, 2023 -273,000.00
Sep 30, 2023 235,000.00
Jun 30, 2023 3.43 Mn
Mar 31, 2023 347,000.00
API Access

Mereo BioPharma Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=MREO&period=max&api_key=YOUR_API_KEY